Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults

Hedi Schelleman; Warren B. Bilker; Stephen E. Kimmel; Gregory W. Daniel; Craig Newcomb; James P. Guevara; Mark J. Cziraky; Brian L. Strom; Sean Hennessy

doi:10.1371/journal.pone.0052991

Loading metrics

Open Access

Peer-reviewed

Research Article

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults

Hedi Schelleman,

Affiliation Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯
Warren B. Bilker,

Affiliations Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Center for Pharmacoepidemiololgy Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯
Stephen E. Kimmel,

Affiliations Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Center for Pharmacoepidemiololgy Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Center for Therapeutic Effectiveness Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯
Gregory W. Daniel,

Affiliation Engelberg Center for Health Care Reform, The Brookings Institution, Washington, District of Columbia, United States of America
⨯
Craig Newcomb,

Affiliation Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯
James P. Guevara,

Affiliations Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Center for Pharmacoepidemiololgy Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, PolicyLab: Center to Bridge Research, Practice, and Policy, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States of America
⨯
Mark J. Cziraky,

Affiliation HealthCore, Inc., Wilmington, Delaware, United States of America
⨯
Brian L. Strom,

Affiliations Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Center for Pharmacoepidemiololgy Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Center for Therapeutic Effectiveness Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯
Sean Hennessy

* E-mail: hennessy@upenn.edu

Affiliations Center for Clinical Epidemiology and Biostatistics, and Department of Biostatistics & Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Center for Pharmacoepidemiololgy Research and Training, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America, Center for Therapeutic Effectiveness Research, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, United States of America
⨯

Amphetamines, Atomoxetine and the Risk of Serious Cardiovascular Events in Adults

Hedi Schelleman,
Warren B. Bilker,
Stephen E. Kimmel,
Gregory W. Daniel,
Craig Newcomb,
James P. Guevara,
Mark J. Cziraky,
Brian L. Strom,
Sean Hennessy

Published: January 30, 2013
https://doi.org/10.1371/journal.pone.0052991

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Amphetamines
Is the Subject Area "Amphetamines" applicable to this article?

Thanks for your feedback.
Cardiology
Is the Subject Area "Cardiology" applicable to this article?

Thanks for your feedback.
Cardiovascular disease risk
Is the Subject Area "Cardiovascular disease risk" applicable to this article?

Thanks for your feedback.
Myocardial infarction
Is the Subject Area "Myocardial infarction" applicable to this article?

Thanks for your feedback.
Arrhythmia
Is the Subject Area "Arrhythmia" applicable to this article?

Thanks for your feedback.
ADHD
Is the Subject Area "ADHD" applicable to this article?

Thanks for your feedback.
Stroke
Is the Subject Area "Stroke" applicable to this article?

Thanks for your feedback.
Epidemiology
Is the Subject Area "Epidemiology" applicable to this article?

Thanks for your feedback.